Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis

Journal of Rheumatology

Volumn 33, Issue 8, 2006, Pages 1691-1693

  Nakamura, Hideki ^a   Kawakami, Atsushi ^a   Ida, Hiroaki ^a   Ejima, Eri ^a   Origuchi, Tomoki ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Calcinosis; Juvenile dermatomyositis; Phosphorus; Probenecid

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CIMETIDINE; CORTICOSTEROID; CYCLOSPORIN A; PHOSPHORUS; PREDNISOLONE; PROBENECID;

ARTICLE; CALCINOSIS; CASE REPORT; DERMATOMYOSITIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; JOINT CONTRACTURE; JOINT FUNCTION; MALE; PHOSPHATE BLOOD LEVEL; PHYSICAL DISABILITY; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; SKIN INFECTION;

ANTI-INFLAMMATORY AGENTS; CALCINOSIS; CHILD; CYCLOSPORINE; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KNEE JOINT; MALE; PREDNISOLONE; PROBENECID; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME; URICOSURIC AGENTS;

EID: 33746706215     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Haibert AR. Juvenile dermatomyositis. Australas J Dermatol 1996;37:106-8.
2. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47:505-11.
3. Ansell BM. Management of polymyositis and dermatomyositis. Clin Rheum Dis 1984;10:205-13.
4. Huber AM, Lang B, LeBlanc CM, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9.
5. Shehata R, al-Mayouf S, al-Dalaan A, al-Mazaid A, al-Balaa S, Bahabri S. Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol 1999;17:115-8.
6. Downey EC Jr, Woolley MM, Hanson V. Required surgical therapy in the pediatric patient with dermatomyositis. Arch Surg 1988;123:1117-20.
7. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 2001;138:763-6.
8. Skuterud E, Sydnes OA, Haavik TK. Calcinosis in dermatomyositis treated with probenecid. Scand J Rheumatol 1981;10:92-4.
9. Eddy MC, Leelawattana R, McAlister WH, Whyte MP. Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy. J Clin Endocrinol Metab 1997;82:3536-42.
10. Harel L, Harel G, Korenreich L, Straussberg R, Amir J. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 2001;28:1129-32.
11. Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975;2:309-10.